PPMD Community

Webinar: Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne

Event Details

Webinar: Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne

Time: October 15, 2014 from 12pm to 1pm
Location: Eastern Time Zone
Website or Map: http://www.readytalk.com/
Phone: 866.740.1260 -- Access code: 9449985
Event Type: webinar, santhera
Organized By: PPMD
Latest Activity: Oct 23, 2014

Export to Outlook or iCal (.ics)

Event Description

Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne: Results of the phase 3 double-blind, randomized, placebo-controlled DELOS trial

Santhera Pharmaceuticals presented data of the Phase III DELOS trial during a webinar hosted by Parent Project Muscular Dystrophy on Wednesday, October 15th at 12pm eastern

Presenters:

  • Prof. Gunnar Buyse (University Hospitals Leuven, Belgium); PI of the study
  • Thomas Meier PhD, CEO of Santhera Pharmaceuticals

Santhera Questions:

Santhera has provided answers to some patient questions in the PDF downloads below. Additional questions were also addressed during the webinar.

Webinar Recording:


Comment Wall

Comment

RSVP for Webinar: Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne to add comments!

Join PPMD Community

Attending (5)

Might attend (1)

© 2017   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service